Jazz product sales will beat Q1's high estimate on price increases alone, but there is much room to grow organically. Jazz Pharmaceuticals is a large biopharmaceutical company with a market cap of $10.63 billion.
http://ift.tt/1GcQGiR
http://ift.tt/1GcQGiR
No comments:
Post a Comment